New diabetes clinical trial: Does the Use of Fiasp vs. Asp Lead to the Prolonged TIR in Children With Type 1 Diabetes?
Published on: February 26, 2021 at 10:30PM
Conditions: Diabetes type1; Diabetes Mellitus, Type 1
Intervention: Drug: Insulin faster aspart (Fiasp, Novo Nordisk)
Sponsor: Medical University of Warsaw
Not yet recruiting
https://ift.tt/2O3XGuq
Conditions: Diabetes type1; Diabetes Mellitus, Type 1
Intervention: Drug: Insulin faster aspart (Fiasp, Novo Nordisk)
Sponsor: Medical University of Warsaw
Not yet recruiting
https://ift.tt/2O3XGuq
Comments
Post a Comment